On April 26, 2017, the Drug Policy Alliance (DPA), together with some of its strongest supporters, gathered to celebrate the career and resignation of the organization’s Founder and Executive Director, Ethan Nadelman. Tears were shed by family and friends alike, as DPA staff recounted the manner by which Nadelman, a New York native, championed drug reform over the course of decades, working from a basement office with a handful of volunteers, to a global organization that is over 70 employees strong. And when Nadelman took the stage, he wasted no time in thanking his loyal team and describing his emotions, hurdles, and accomplishments as he dared to challenge the failed War on Drugs and the unfortunate – and apparently purposeful — disproportionate effect that the War on Drugs has had on people of color and minority communities. When Nadelman first embraced this cause, it was hardly mainstream.
Funded by philanthropist and investor George Soros, among others, DPA seeks to reform drug laws and promote sensible drug policy and “harm reduction” – i.e., initiatives designed to reduce negative consequences associated with drug use and addiction….